AU2002216758A1 - Quinazolines with therapeutic use - Google Patents
Quinazolines with therapeutic useInfo
- Publication number
- AU2002216758A1 AU2002216758A1 AU2002216758A AU1675802A AU2002216758A1 AU 2002216758 A1 AU2002216758 A1 AU 2002216758A1 AU 2002216758 A AU2002216758 A AU 2002216758A AU 1675802 A AU1675802 A AU 1675802A AU 2002216758 A1 AU2002216758 A1 AU 2002216758A1
- Authority
- AU
- Australia
- Prior art keywords
- quinazolines
- therapeutic use
- therapeutic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00401897 | 2000-07-03 | ||
| EP00401897 | 2000-07-03 | ||
| PCT/GB2001/002874 WO2002002534A1 (en) | 2000-07-03 | 2001-06-28 | Quinazolines with therapeutic use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002216758A1 true AU2002216758A1 (en) | 2002-01-14 |
Family
ID=8173753
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002216758A Abandoned AU2002216758A1 (en) | 2000-07-03 | 2001-06-28 | Quinazolines with therapeutic use |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2002216758A1 (en) |
| WO (1) | WO2002002534A1 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60112268T2 (en) | 2000-03-06 | 2006-05-24 | Astrazeneca Ab | USE OF QUINAZOLIN DERIVATIVES AS INHIBITORS OF ANGIOGENESIS |
| WO2002036587A2 (en) | 2000-11-01 | 2002-05-10 | Cor Therapeutics, Inc. | Process for the production of 4-quinazolinylpiperazin-1-carboxylic acid phenylamides |
| JP4690889B2 (en) | 2002-10-24 | 2011-06-01 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | Methylene urea derivative |
| JP5032851B2 (en) | 2004-02-03 | 2012-09-26 | アストラゼネカ アクチボラグ | Quinazoline derivatives |
| CN102250112A (en) * | 2010-05-18 | 2011-11-23 | 上海再启生物技术有限公司 | Preparation method of 7-bromine-4-amino-thienopyrimidine |
| WO2014147246A1 (en) | 2013-03-21 | 2014-09-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Method and pharmaceutical composition for use in the treatment of chronic liver diseases associated with a low hepcidin expression |
| CN103232429B (en) * | 2013-04-26 | 2015-03-11 | 绍兴民生医药有限公司 | Preparation method of (E)-N-[3-(methylamino)propyl]-3-(thiophene-2-yl) acrylamide and salt thereof |
| CN103265481A (en) * | 2013-06-14 | 2013-08-28 | 苏州明锐医药科技有限公司 | Preparation method of 4-amino-3-quinoline formonitrile derivative |
| CN115215807A (en) | 2016-08-26 | 2022-10-21 | 科泰纳制药公司 | Inhibition of OLIG2 activity |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CO4940469A1 (en) * | 1997-03-05 | 2000-07-24 | Sugen Inc | ORAL COMPOSITION OF IMPROVED STABILITY INCLUDING A DERIVATIVE OF INDOLINONE AND A MIXTURE OF GLYCERIDES OR POLYETHYLENE GLYCOL ESTERS |
| UA73073C2 (en) * | 1997-04-03 | 2005-06-15 | Уайт Холдінгз Корпорейшн | Substituted 3-cyan chinolines |
| AR012634A1 (en) * | 1997-05-02 | 2000-11-08 | Sugen Inc | QUINAZOLINE BASED COMPOUND, FAMACEUTICAL COMPOSITION THAT UNDERSTANDS IT, METHOD TO SYNTHESIZE IT, ITS USE, METHODS OF MODULATION OF THE DESERINE / TREONIN PROTEIN-KINASE FUNCTION AND IN VITRO METHOD TO IDENTIFY COMPOUNDS THAT MODULATE |
| AR016817A1 (en) * | 1997-08-14 | 2001-08-01 | Smithkline Beecham Plc | DERIVATIVES OF FENILUREA OR FENILTIOUREA, PROCEDURE FOR PREPARATION, COLLECTION OF COMPOUNDS, INTERMEDIARY COMPOUNDS, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT AND USE OF SUCH COMPOUNDS FOR THE MANUFACTURE OF A MEDICINAL PRODUCT |
-
2001
- 2001-06-28 AU AU2002216758A patent/AU2002216758A1/en not_active Abandoned
- 2001-06-28 WO PCT/GB2001/002874 patent/WO2002002534A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002002534A1 (en) | 2002-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001256184A1 (en) | 6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viraldiseases | |
| AU2001252135A1 (en) | Therapeutic agents | |
| AU2002212436A1 (en) | Quinazoline derivatives | |
| AU2002219135A1 (en) | Substituted 2-anilino-benzimidazoles and the use thereof as NHE-inhibitors | |
| AU2002235175A1 (en) | Lometrexol combination therapy | |
| AU2001240637A1 (en) | Novel imidazotriazinones and the use thereof | |
| AU9153601A (en) | Portable sauna | |
| AU2001292137A1 (en) | Quinazoline derivatives | |
| AU2001268525A1 (en) | Human kinases | |
| AU2001288612A1 (en) | Human kinases | |
| AU2001238488A1 (en) | Human kinases | |
| AU2001277959A1 (en) | Human kinases | |
| AU2001236562A1 (en) | Portable spa | |
| AU2002216758A1 (en) | Quinazolines with therapeutic use | |
| AU2001273903A1 (en) | Therapeutic agents | |
| AU2000231564A1 (en) | Phosphororganic compounds and the use thereof | |
| AU4432001A (en) | Trityl-type compounds and their use | |
| AU2001260236A1 (en) | Restricted use syringe | |
| AU2001255573A1 (en) | Human kinases | |
| AU2002227352A1 (en) | Human kinases | |
| GB0018887D0 (en) | Compound and their therapeutic use | |
| AU2002339178A1 (en) | Quinazoline compounds with therapeutic use | |
| AU2001292897A1 (en) | Novel therapy | |
| AU6286101A (en) | New use | |
| AU2001278963A1 (en) | Muo-conopeptides and their use as local anesthetics |